Hindustan Bio Sciences Limited (BOM:532041)
India · Delayed Price · Currency is INR 7.20
+0.16 (2.27%)
At close: Jul 31, 2026
Hindustan Bio Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 1.3 | 0.11 | 0.35 | 0.1 | 0.09 |
Cash & Short-Term Investments | 1.3 | 1.3 | 0.11 | 0.35 | 0.1 | 0.09 |
Cash Growth | 1095.41% | 1095.41% | -68.86% | 266.98% | 4.50% | -45.33% |
Receivables | - | 0.53 | 4.42 | 4.42 | 4.54 | 1.35 |
Other Current Assets | - | 5.89 | 5.44 | 4.73 | 3.97 | 3.97 |
Total Current Assets | - | 7.72 | 9.97 | 9.5 | 8.6 | 5.41 |
Property, Plant & Equipment | - | 0.13 | 0.27 | 0.27 | 0.34 | 0.4 |
Long-Term Deferred Tax Assets | - | 0.1 | 0.1 | 0.07 | 0.03 | 0.06 |
Other Long-Term Assets | - | 24 | 23.9 | 23.9 | 23.9 | 23.9 |
Total Assets | - | 31.95 | 34.24 | 33.74 | 32.87 | 29.76 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | - | 0.01 | 0.02 | 0.65 | 0.01 |
Accrued Expenses | - | 0.19 | 0.13 | 0.12 | 0.2 | 0.21 |
Short-Term Debt | - | - | - | - | 13.33 | 10.95 |
Other Current Liabilities | - | 0.01 | - | - | - | - |
Total Current Liabilities | - | 0.2 | 0.14 | 0.14 | 14.18 | 11.17 |
Long-Term Debt | - | 23.5 | 25.05 | 25.56 | 11.22 | 10.72 |
Other Long-Term Liabilities | - | - | 0 | - | - | 0 |
Total Liabilities | - | 23.69 | 25.19 | 25.7 | 25.4 | 21.89 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 20.5 | 20.5 | 20.5 | 20.5 | 102.51 |
Retained Earnings | - | -12.24 | -11.45 | -12.46 | -13.04 | -94.64 |
Comprehensive Income & Other | - | - | -0 | - | - | - |
Shareholders' Equity | 8.26 | 8.26 | 9.05 | 8.04 | 7.47 | 7.87 |
Total Liabilities & Equity | - | 31.95 | 34.24 | 33.74 | 32.87 | 29.76 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 23.5 | 23.5 | 25.05 | 25.56 | 24.55 | 21.67 |
Net Cash (Debt) | -22.19 | -22.19 | -24.94 | -25.21 | -24.46 | -21.57 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.49 | -2.25 | -2.43 | -2.46 | -2.39 | -2.10 |
Filing Date Shares Outstanding | 10.26 | 10.6 | 10.25 | 10.25 | 10.25 | 10.25 |
Total Common Shares Outstanding | 10.26 | 10.6 | 10.25 | 10.25 | 10.25 | 10.25 |
Working Capital | - | 7.52 | 9.83 | 9.36 | -5.58 | -5.76 |
Book Value Per Share | 0.78 | 0.78 | 0.88 | 0.78 | 0.73 | 0.77 |
Tangible Book Value | 8.26 | 8.26 | 9.05 | 8.04 | 7.47 | 7.87 |
Tangible Book Value Per Share | 0.78 | 0.78 | 0.88 | 0.78 | 0.73 | 0.77 |
Machinery | - | - | 5.37 | 5.37 | 5.37 | 5.37 |